Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Reactogenicity and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants
This study has been completed.
Study NCT01437267   Information provided by Novartis Vaccines Institute for Global Health

First Received on September 19, 2011.   Last Updated on September 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Typhoid Fever
More general conditions related to this trial
Bacterial Infections
Enterobacteriaceae Infections
Gram-Negative Bacterial Infections
Salmonella Infections
Interventions listed in this trial
NVGH Vi-CRM197 vaccine
Pneumococcal conjugate vaccine
Vi Polysaccharide (PS) vaccine
Sponsors listed in this trial
Novartis Vaccines Institute for Global Health


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services